Making Sense of Today’s 340B Policy Entanglements As covered entities face rising healthcare costs, reimbursement cuts, and uncompensated care, the Federal 340B Drug Pricing Program continues to be an important source of funding for vital patient care. Get updates on how the 340B program solutions can help providers manage reporting compliance across an incr ... Show More
Oct 8
Live from the FrameworkLTC Innovation Conference (Part 1) | FrameworkFocus™
In part one of our special three-part series, join host Todd Eury as he takes you inside the 2025 FrameworkLTC Innovation Conference. Recorded live on-site, this episode features conversations with long-term care (LTC) pharmacy leaders, partner exhibitors, and members of the Soft ... Show More
32m 47s
Sep 2023
Money Talks: The price of cheaper medicines
One of the many aims of President Joe Biden’s signature legislation, the Inflation Reduction Act, is to cut the cost of drugs prescribed by Medicare, a government health insurance programme for Americans 65 and over. But the policy could have some side-effects for patients far be ... Show More
44m 53s
Sep 2023
Money Talks: The price of cheaper medicines
One of the many aims of President Joe Biden’s signature legislation, the Inflation Reduction Act, is to cut the cost of drugs prescribed by Medicare, a government health insurance programme for Americans 65 and over. But the policy could have some side-effects for patients far be ... Show More
44m 53s
Nov 2023
CVS vs. Walgreens | Trouble Behind the Counter | 5
Between overworked pharmacists, healthcare consolidation, and rising drug costs, pharmacies are constantly having to adapt. Dan Weissmann, host of the An Arm and a Leg podcast, joins David to talk about how these conditions are affecting pharmacies — big and small — and consumers ... Show More
42m 21s
Nov 2023
For ACA Plans, It’s Time to Shop Around
It’s Obamacare open enrollment season, which means that, for people who rely on these plans for coverage, it’s time to shop around. With enhanced premium subsidies and cost-sharing assistance, consumers may find savings by switching plans. It is especially important for people wh ... Show More
28m 46s
Jun 2016
Bloomberg Surveillance: Bloomberg BNA's Eleanor Tyler on pharma
Bloomberg BNA's Eleanor Tyler joins Tom Keene and Mike McKee to discuss pharmaceutical mergeres, tax inversions, drug pricing, and the renewed efforts by the Federal Trade Commission to regulate an increasingly complicated industry. Learn more about your ad-choices at https://www ... Show More
6m 38s